NANOG and prostate carcinoma: The reason for the discrepancy between the findings of the current study and those reported by others is not known; however, differences between prostate cancer obtained from biopsy specimens and human prostate cancer cell lines may have influenced the stainability of the four different stem cell markers, NANOG, OCT4, CD133 and NESTIN.